At a glance
ClinicalIndex Comparison Record- ✓Current opioid dependence
- ✓Recently completed opioid detoxification
- ✕Serious medical or psychiatric condition requiring immediate hospitalization or that would make participation hazardous
- ✕Planning to leave the study area within 12 months of entry
- ✕Imminent incarceration
- ✕Pregnancy
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Addiction Treatment in Russia: Oral and Depot Naltrexone
In Brief
A Phase 3 clinical trial evaluating naltrexone implant, oral naltrexone, and 2 other interventions for Heroin Dependence and Opioid-Related Disorders. Completed, enrolled 306 participants across 2 sites in 2 countries.
Detailed Summary
Heroin addiction is a growing problem in Russia; individuals who enter heroin addiction treatment often relapse. Therefore, effective heroin addiction treatments are necessary to prevent relapse. The purpose of this study is to compare oral naltrexone with a naltrexone implant that provides opioid blockade for two months in preventing relapse to heroin addiction in St. Petersburg, Russia.
Study Details
Timeline
Interventions
naltrexone implant is 1000 mg naltrexone
oral naltrexone 50 mg/day
oral placebo naltrexone resembles active medication
placebo implant resembles active medication